Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Join | Sign in
Home>Resources>White Papers>This White Paper
  White Papers
Scientific News
Drinking Raw Milk Dramatically Increases Risk for Foodborne Illness, Analysis Finds
Researchers discourage the consumption of raw milk, especially by children, pregnant women and the elderly.
Immunomagnetic Assay On-a-Chip Captures, Analyzes Circulating Tumor Cells
Dartmouth researchers and bioengineers develop novel system to improve cancer treatment.
Genome Study Predicts DNA of the Whole of Iceland
Large genome databases are starting to reveal critical health information-even about people who have not contributed their DNA.
How the Human Immune System Keeps TB at Bay
Scientists create model of host, bacteria behavior in latent TB infection.
MDC Researchers Greatly Increase Precision of New Genome Editing Tool
“One of the hottest topics in science and an innovative field”.
‘Atomic Chicken-Wire’ Is Key To Faster DNA Sequencing
An unusual and very exciting form of carbon - that can be created by drawing on paper- looks to hold the key to real-time, high throughput DNA sequencing, a technique that would revolutionise medical research and testing.
The Switch That Might Tame The Most Aggressive Of Breast Cancers
Garvan researchers have found that so-called ‘triple-negative breast cancers’ are two distinct diseases that likely originate from different cell types. They have also found a gene that drives the aggressive disease, and hope to find a way to ‘switch it off’.
Gene Editing Technique Mastered In Mosquito That Transmits Deadly Diseases
Technique will help researchers learn more about the role of genes that are involved in mosquito propagation.
Genetic Mutation Helps Explain Why, In Rare Cases, Flu Can Kill
Study shows that immune response to flu can be affected by a rare genetic mutation.
The Colour Of Lettuce Determines The Speed Of Its Antioxidant Effect
A study by the UPV/EHU-University of the Basque Country has explored the kinetics in the Batavia, Marvel of Four Seasons and Oak Leaf lettuces.
Scroll Up
Scroll Down

Microarray Platform Comparisons – Commentary on Barnes et al. (2005)
Bookmark and Share
Affymetrix


For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here


Related Content

CollabRx, Affymetrix To Develop Analytical Tools For Integrated Clinical Cancer Panels
The overall objective of the partnership is to provide scientific knowledge for biomarker CNV profiles in cancer.
Wednesday, April 16, 2014
University of Bristol Collaborates with Affymetrix on Genotyping Arrays
Results from the array presented at the 2014 Plant and Animal Genome conference.
Wednesday, January 15, 2014
Affymetrix Reports 2013 First Quarter Results
Affymetrix, Inc. reported its operating results for the three months ended March 31, 2013.
Wednesday, May 01, 2013
Affymetrix and BioDiscovery Announce Software for Analysis of Whole Genome Copy Number Data
Generated from FFPE solid tumor samples for accelerating cancer translational research.
Thursday, April 11, 2013
Ingenuity Systems and Affymetrix Partner
Companies collaborate to eliminate microarray expression analysis bottleneck.
Monday, April 08, 2013
Affymetrix Announces Collaboration with Centre for Proteomic and Genomic Research (CPGR)
CPGR will provide gene expression and Axiom genotyping services to African researchers using GeneTitan® Multi-Channel (MC) Instrument.
Tuesday, November 20, 2012
Affymetrix and Singapore-based Start-up PathGEN Dx Sign Partnership
Agreement for diagnostic test development for pathogen detection.
Monday, August 27, 2012
Affymetrix Completes Acquisition of eBioscience Holding Company, Inc.
Acquisition expands Affymetrix’s addressable markets by more than $2.5 billion per year.
Thursday, June 28, 2012
Affymetrix Announces Proposed $105 Million Offering of Convertible Senior Notes Due 2019
Company expects to grant an option to purchase up to $10 million aggregate principal amount of additional notes.
Thursday, June 21, 2012
Affymetrix Announces Research Collaboration with MGH
Collaboration and licensing agreement to validate and develop new oncology biomarker tests.
Thursday, June 07, 2012
Affymetrix and Leica Microsystems Announce Worldwide Collaboration
The collaboration automates Affymetrix’ QuantiGene® ViewRNA ISH Tissue Assay on the Leica BOND RX staining platform for research applications.
Thursday, May 31, 2012
Affymetrix and ScreenCell Announce Worldwide Distribution Agreement for CTC Technology
Combination of ScreenCell’s isolation devices and Affymetrix’ QuantiGene® ViewRNA ISH technology enables easy, accessible, sensitive, multiplex, low-cost system to enumerate and characterize CTCs and other rare cells.
Friday, May 18, 2012
Affymetrix and ScreenCell Announce Worldwide Distribution Agreement
Affymetrix releases first circulating tumour cell platform technology for 4-color RNA-ISH.
Friday, May 18, 2012
Affymetrix and BGI Enter Strategic Collaboration
Partnership to co-develop and commercialize genomic microarrays for the agricultural community.
Friday, January 13, 2012
Affymetrix to Acquire eBioscience
Under the terms of the agreement, Affymetrix will acquire eBioscience for $330 million in cash subject to certain customary adjustments. The transaction is subject to customary closing conditions.
Wednesday, December 14, 2011
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters